RECURSION PHARMACEUTICALS, INC.

RXRXNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$74.7M

▲ 26.9% YoY

Net Income

-$644.8M

▼ 39.1% YoY

EPS

$-1.44

▲ 14.8% YoY

Cash

$743.3M

▲ 25.1% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.